Irish researchers test alpha-1-antitrypsin for Covid-19
Researchers at RCSI University of Medicine and Health Sciences in Ireland have started a clinical...
Read More...
Focus:
Ireland
-
Accenture and Bayer to implement INTIENT Clinical platform
Accenture will partner with Bayer to implement the Accenture INTIENT Clinical platform for research, clinical...
Read More...
-
PCI Pharma to invest in new clinical facility in Dublin
PCI Pharma is set to invest in a new clinical facility near Dublin, Ireland to...
Read More...
-
![]()
Alkermes reports positive results for Aristada in schizophrenia
Irish biopharmaceutical company Alkermes has reported positive top-line data from the Phase IIIb ALPINE clinical...
Read More...
-
Phase III trial of JZP-258 to treat EDS meets primary endpoint
Jazz Pharmaceuticals has announced that the Phase III trial of JZP-258 for the treatment of...
Read More...
-
![]()
Allergan’s depression drug fails in Phase III trials
Allergan has reported top-line results from three pivotal Phase III clinical trials of depression drug...
Read More...
-
![Controlled trial offers hope for restoring vision in LSCD patients]()
Horizon Pharma announces positive results for teprotumumab
Ireland-based Horizon Pharma has announced positive top-line results from the Phase III confirmatory trial of...
Read More...
-
Deals this week: Roivant Sciences, Inflazome, Santhera
Roivant Sciences will use biologic drug candidate SAL200 are entering a global licensing agreement worth...
Read More...
-
![]()
Shire reports positive data from Phase III lanadelumab trial
Shire has reported positive results from the Phase III hereditary angioedema long-term prophylaxis (HELP) trial...
Read More...
-
![]()
Allergan assesses brazikumab in two clinical programmes for IBD
Allergan has commenced two clinical research programmes, INTREPID and EXPEDITION, to assess the safety and...
Read More...
